Injecting too deeply (into muscle) can cause pain, bruising, and altered absorption, whilst too shallow an injection may cause medication leakage or skin irritation
International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription
BodyBio Liposomal Glutathione supports cellular health from the ground up, providing the antioxidant protection every cell needs to maintain its processing capacity
Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinsons disease
High levels of this protein are observed in critical illnesses, including organ failure, SIRS, and sepsis [15]
Liraglutide (3.0 mg once daily) and semaglutide (2.4 mg once weekly) are the only GLP-1 receptor agonists that have been approved for weight management